IRSD, U1220, Université de Toulouse, INSERM, INRA, ENVT, UPS, Toulouse, France.
Institut de Pharmacologie et de Biologie Structurale, Université de Toulouse, CNRS, UPS, Toulouse, France.
Sci Rep. 2018 May 18;8(1):7834. doi: 10.1038/s41598-018-26282-y.
While proteases are essential in gastrointestinal physiology, accumulating evidence indicates that dysregulated proteolysis plays a pivotal role in the pathophysiology of inflammatory bowel disease (IBD). Nonetheless, the identity of overactive proteases released by human colonic mucosa remains largely unknown. Studies of protease abundance have primarily investigated expression profiles, not taking into account their enzymatic activity. Herein we have used serine protease-targeted activity-based probes (ABPs) coupled with mass spectral analysis to identify active forms of proteases secreted by the colonic mucosa of healthy controls and IBD patients. Profiling of (Pro-Lys)-ABP bound proteases revealed that most of hyperactive proteases from IBD secretome are clustered at 28-kDa. We identified seven active proteases: the serine proteases cathepsin G, plasma kallikrein, plasmin, tryptase, chymotrypsin-like elastase 3 A, and thrombin and the aminopeptidase B. Only cathepsin G and thrombin were overactive in supernatants from IBD patient tissues compared to healthy controls. Gene expression analysis highlighted the transcription of genes encoding these proteases into intestinal mucosae. The functional ABP-targeted proteomic approach that we have used to identify active proteases in human colonic samples bears directly on the understanding of the role these enzymes may play in the pathophysiology of IBD.
虽然蛋白酶在胃肠道生理学中是必不可少的,但越来越多的证据表明,调节失常的蛋白水解在炎症性肠病(IBD)的病理生理学中起着关键作用。尽管如此,由人结肠黏膜释放的过度活跃的蛋白酶的身份在很大程度上仍然未知。蛋白酶丰度的研究主要调查了表达谱,而没有考虑到它们的酶活性。在此,我们使用了针对丝氨酸蛋白酶的活性基于探针(ABP)结合质谱分析来鉴定健康对照者和 IBD 患者结肠黏膜分泌的具有活性的蛋白酶形式。(Pro-Lys)-ABP 结合蛋白酶的分析表明,IBD 分泌组中大多数过度活跃的蛋白酶聚集在 28kDa 处。我们鉴定了七种活性蛋白酶:丝氨酸蛋白酶组织蛋白酶 G、血浆激肽释放酶、纤溶酶、糜蛋白酶样弹性蛋白酶 3A、凝血酶和氨基肽酶 B。与健康对照者相比,只有组织蛋白酶 G 和凝血酶在来自 IBD 患者组织的上清液中过度活跃。基因表达分析突出了编码这些蛋白酶的基因在肠黏膜中的转录。我们用于鉴定人结肠样本中活性蛋白酶的基于 ABP 的靶向蛋白质组学方法直接影响对这些酶在 IBD 病理生理学中可能发挥的作用的理解。